Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2022 Sep 5;7(1):308.
doi: 10.1038/s41392-022-01164-y.

Circulating tumor DNA analysis: potential to revise adjuvant therapy for stage II colorectal cancer

Ning Zhu #  1   2 , Hanguang Hu #  1 , Ying Yuan  3   4   5
Affiliations
Comment

Circulating tumor DNA analysis: potential to revise adjuvant therapy for stage II colorectal cancer

Ning Zhu et al. Signal Transduct Target Ther. .
No abstract available

PubMed Disclaimer

Conflict of interest statement

The author declares no competing interests.

Comment on

  • Circulating Tumor DNA Analysis Guiding Adjuvant Therapy in Stage II Colon Cancer.
    Tie J, Cohen JD, Lahouel K, Lo SN, Wang Y, Kosmider S, Wong R, Shapiro J, Lee M, Harris S, Khattak A, Burge M, Harris M, Lynam J, Nott L, Day F, Hayes T, McLachlan SA, Lee B, Ptak J, Silliman N, Dobbyn L, Popoli M, Hruban R, Lennon AM, Papadopoulos N, Kinzler KW, Vogelstein B, Tomasetti C, Gibbs P; DYNAMIC Investigators. Tie J, et al. N Engl J Med. 2022 Jun 16;386(24):2261-2272. doi: 10.1056/NEJMoa2200075. Epub 2022 Jun 4. N Engl J Med. 2022. PMID: 35657320 Free PMC article. Clinical Trial.

References

    1. Tie J, et al. Circulating tumor DNA analysis guiding adjuvant therapy in stage II colon cancer. N. Engl. J. Med. 2022;386:2261–2272. doi: 10.1056/NEJMoa2200075. - DOI - PMC - PubMed
    1. Tournigand C, et al. Adjuvant therapy with fluorouracil and oxaliplatin in stage II and elderly patients (between ages 70 and 75 years) with colon cancer: subgroup analyses of the Multicenter International Study of Oxaliplatin, Fluorouracil, and Leucovorin in the Adjuvant Treatment of Colon Cancer trial. J. Clin. Oncol. 2012;30:3353–3360. doi: 10.1200/JCO.2012.42.5645. - DOI - PubMed
    1. Yuan Z, et al. CSCO guidelines for colorectal cancer version 2022: updates and discussions. Chin. J. Cancer Res. 2022;34:67–70. doi: 10.21147/j.issn.1000-9604.2022.02.01. - DOI - PMC - PubMed
    1. Moding EJ, Nabet BY, Alizadeh AA, Diehn M. Detecting liquid Remnants of solid tumors: circulating tumor DNA minimal Residual Disease. Cancer Discov. 2021;11:2968–2986. doi: 10.1158/2159-8290.CD-21-0634. - DOI - PMC - PubMed
    1. Henriksen TV, et al. The effect of surgical trauma on circulating free DNA levels in cancer patients-implications for studies of circulating tumor DNA. Mol. Oncol. 2020;14:1670–1679. doi: 10.1002/1878-0261.12729. - DOI - PMC - PubMed

Publication types

MeSH terms

Substances